基于数据挖掘中医药治疗溃疡性结肠炎动物实验的用药规律研究
Study on the Medication Law of Traditional Chinese Medicine in Treating Animal Experiments of Ulcerative Colitis on Data Mining
DOI: 10.12677/acm.2024.1472016, PDF,   
作者: 朱晗昕, 罗玉丹, 董少华:云南中医药大学第一临床医学院,云南 昆明;马青原*:云南中医药大学第一附属医院肛肠科,云南 昆明
关键词: 溃疡性结肠炎中药动物实验数据挖掘用药规律Ulcerative Colitis Traditional Chinese Medicine Animal Experiments Data Mining Medication Law
摘要: 目的:研究分析用中药治疗溃疡性结肠炎动物实验的用药规律。方法:通过对中国知网(CNKI)、万方数据库(WANFANGDATE)及维普中文期刊数据库(VIP)治疗溃疡性结肠炎的动物实验所用中药进行筛选,通过“古今医案云平台”对中药的四气五味、性味归经进行数据分析。结果:最终纳入处方90首,包含中药149味,主归肝、脾、肺经,其中使用频次较高的药物是黄连、甘草、茯苓、黄芩、白及等;结论:溃疡性结肠炎动物实验的治疗以清热解毒为主,辅以健脾、行气、活血化瘀。本研究为溃疡性结肠炎的临床用药提供了参考。
Abstract: Objective: To study and analyze the medication law of traditional Chinese medicines used in animal experiments for the treatment of ulcerative colitis. Methods: The Chinese herbal medicines used in animal experiments for ulcerative colitis were screened in CNKI, WANFANGDATE and VIP databases, and the data of the four-qi and five-flavors and the attributes of the Chinese herbal medicines were analyzed by the “Ancient and Modern Medical Case Cloud Platform”. Results: 90 prescriptions were included, containing 149 flavors of traditional Chinese medicines, which were mainly classified into the liver, spleen and lung meridians, and the most frequently used medicines were Huang Lian, Gan Cao, Poria, Scutellaria baicalensis, Bai Ji, etc. Conclusion: The treatment of ulcerative colitis in animal experiments is based on clearing away heat and removing toxins, and is supplemented by strengthening the spleen, promoting circulation of qi, and activating blood circulation and removing blood stasis. This study provides a reference for the clinical medication of ulcerative colitis.
文章引用:朱晗昕, 马青原, 罗玉丹, 董少华. 基于数据挖掘中医药治疗溃疡性结肠炎动物实验的用药规律研究[J]. 临床医学进展, 2024, 14(7): 313-320. https://doi.org/10.12677/acm.2024.1472016

参考文献

[1] Zhang, B., Liu, K., Yang, H., et al. (2022) Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method-UC and T2DM as Examples. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 855075. [Google Scholar] [CrossRef] [PubMed]
[2] 曾思敏, 林武红, 罗鹏基, 等. 溃疡性结肠炎的中医药治疗进展[J]. 辽宁中医杂志, 2020, 47(6): 209-212.
[3] 付琳, 付强, 李冀, 等. 黄连化学成分及药理作用研究进展[J]. 中医药学报, 2021, 49(2): 87-92.
[4] Li, N., Gu, L.L., Qu, L.L., et al. (2010) Berberine Attenuates Pro-Inflammatory Cytokine-Induced Tight Junction Disruption in an in vitro Model of Intestinal Epithelial Cells. European Journal of Pharmaceutical Sciences, 40, 1-8. [Google Scholar] [CrossRef] [PubMed]
[5] 陈阳, 马嘉仪, 张健榕, 等. 黄连中生物碱类成分抗溃疡性结肠炎的作用机制研究进展[J]. 南京中医药大学学报, 2023, 39(12): 1260-1266.
[6] 李娜, 张晨, 钟赣生, 等. 不同品种甘草化学成分、药理作用的研究进展及质量标志物(Q-Marker)预测分析[J]. 中草药, 2021, 52(24): 7680-7692.
[7] 左军, 祁天立, 胡晓阳. 茯苓化学成分及现代药理研究进展[J]. 中医药学报, 2023, 51(1): 110-114. [Google Scholar] [CrossRef
[8] 邓桃妹, 彭代银, 俞年军, 等. 茯苓化学成分和药理作用研究进展及质量标志物的预测分析[J]. 中草药, 2020, 51(10): 2703-2717
[9] 孔伟华, 徐建波, 崔琦, 等. 白及化学成分、药理作用和白及多糖提取工艺的研究进展[J]. 中医药信息, 2021, 38(9): 69-78.
[10] 杨乐, 徐梦婷, 蔡琳玲, 等. UHPLC-TOF-MS结合网络药理学与实验验证探讨香连丸治疗溃疡性结肠炎的作用机制[J]. 中国药学杂志, 2023, 58(12): 1084-1092.
[11] 查正霞, 刘艳丽, 许琼明. 白头翁中三萜皂苷类成分的药理研究进展[J]. 中药新药与临床药理, 2020, 31(1): 120-124.
[12] 孔伟华, 徐建波, 崔琦, 等. 白及化学成分、药理作用和白及多糖提取工艺的研究进展[J]. 中医药信息, 2021, 38(9): 69-78.